Compare WING & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WING | TXG |
|---|---|---|
| Founded | 1994 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.4B |
| IPO Year | 2015 | 2019 |
| Metric | WING | TXG |
|---|---|---|
| Price | $173.57 | $38.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 27 | 15 |
| Target Price | ★ $295.92 | $20.25 |
| AVG Volume (30 Days) | 1.0M | ★ 3.5M |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.70% | N/A |
| EPS Growth | 67.84 | ★ 76.97 |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $696,853,000.00 | $245,893,000.00 |
| Revenue This Year | $17.20 | N/A |
| Revenue Next Year | $15.86 | $7.33 |
| P/E Ratio | $164.86 | ★ N/A |
| Revenue Growth | 11.35 | ★ 68.06 |
| 52 Week Low | $116.35 | $11.17 |
| 52 Week High | $381.45 | $40.08 |
| Indicator | WING | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 62.95 | 70.11 |
| Support Level | $139.01 | $16.11 |
| Resistance Level | $204.64 | N/A |
| Average True Range (ATR) | 8.85 | 2.34 |
| MACD | 2.23 | 0.39 |
| Stochastic Oscillator | 89.53 | 86.31 |
Wingstop is a fast casual restaurant concept built around a simple chicken-centric menu. The firm primarily offers bone-in and boneless wings, tenders, and a chicken sandwich, customizable across 12 flavors. The banner generated $5.3 billion in system sales in 2025 across 3,056 units, with 85% located in the US. Wingstop largely operates as a franchisor, with 98% of units franchised, and earns revenue largely from collecting royalties and advertising fees paid by franchisees, with a smaller contribution from company-owned restaurant sales.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).